What is the primary business model of Joey New York according to the deck?

Joey New York operates as a portfolio company that identifies and acquires existing beauty and wellness businesses. As of the 2017 deck, their primary focus was 'The LABB,' a luxury beauty suite specializing in FDA-approved injectable services like Botox and soft tissue fillers. They aim to enhance these businesses through quality management and strategic marketing talent.

What are the reported unit economics for The LABB locations?

Slide 3 reports that The LABB locations generate between $2 million and $5 million in revenue per chair. The company claims to operate with 'low overhead,' resulting in average gross margins of 30%. Additionally, the model is supported by a high customer retention rate, stated as 85% repeat business.

How does the company plan to scale its operations?

The scaling strategy is two-fold: corporate expansion and franchising. Slide 9 details a plan to open 17 additional corporate locations by 2018, targeting high-traffic markets in California, Florida, and Nevada. Following this, the company intended to launch a formal franchise program in 2019 to accelerate growth without the capital intensity of corporate-owned stores.

Who are the key partners mentioned in the presentation?

The deck highlights relationships with major manufacturers in the facial aesthetics space. Specifically, it names Allergan (the maker of Botox) and Galderma as the providers of the FDA-approved injectable fillers used at The LABB locations. This is intended to validate the medical legitimacy of their service offerings.

What information is missing from this investor deck?

The deck is missing several critical components for a comprehensive investment analysis. There is no detailed 'Team' slide listing individual names, titles, or specific past successes. It also lacks a clear 'Use of Proceeds' slide, a detailed P&L statement, and a competitive landscape analysis comparing The LABB to other med-spa chains or independent practitioners.

Joey New York Pitch Deck (2017): 11-Slide Breakdown

See all 11 slides of the Joey New York pitch deck — a 2017 deck — with a slide-by-slide teardown of what the deck does well and where it falls short.

The January 2017 investor presentation for Joey New York (OTC: JOEY) outlines a strategic pivot toward the medical aesthetics market following the acquisition of The LABB Aesthetic Beauty Bar in August 2016. The company positions itself as a portfolio builder in the beauty and wellness space, leveraging a $9.2 billion market opportunity in facial aesthetics. With three initial locations in Florida, the deck projects a rapid expansion to 17 additional sites by 2018 and the launch of a franchise program in 2019. While the deck provides specific unit-level economics, such as $2 million to $5 mil…

Key takeaways

The company is publicly traded on the OTC market under the ticker JOEY as of January 2017 (Slide 1).
Joey New York acquired The LABB Aesthetic Beauty Bar in August 2016 to enter the injectable services market (Slide 3).
Unit economics for The LABB claim $2 million to $5 million in revenue per chair with 30% average gross margins (Slide 3).
The business model relies heavily on repeat customers, citing an 85% repeat business rate (Slide 3).
The facial aesthetics market was projected to grow to $9.2 billion by 2020, representing an 18% CAGR from 2018 (Slide 7).
Expansion plans include opening 17 additional locations across Florida, California, Las Vegas, and NY/CT by 2018 (Slide 9).
The company planned to launch a franchise program in 2019 to further scale the brand (Slide 9).
The deck omits a specific financial 'Ask' or use of proceeds slide, despite the aggressive expansion goals (General Observation).

Joey New York: A Pivot to Medical Aesthetics

The Joey New York investor presentation from January 2017 represents a company in transition. Originally established in 1993 as a skincare brand, the company utilized this deck to communicate its new direction as a publicly traded holding company (OTC: JOEY) focused on high-margin medical aesthetics. The centerpiece of this strategy is the acquisition of The LABB, a specialized beauty bar for injectables. The deck is characterized by bold market projections and specific unit-level performance claims, though it remains light on corporate governance and specific financial requirements.

Slide 1: Title and Public Status

The cover slide establishes the brand identity using stylized fashion illustrations that evoke a high-end, New York aesthetic. Crucially, it identifies the company as OTC: JOEY , signaling to investors that this is a micro-cap public entity rather than a private startup. The date is clearly marked as January 2017, and the logo notes the brand was established in 1993, providing a sense of longevity despite the new business model.

Slide 3: Investment Highlights

This slide serves as the executive summary. It focuses entirely on the acquisition of The Labb Aesthetic Beauty Bar (LABB) , which was completed in August 2016. The key data points provided here are designed to attract investors looking for high-yield retail models:

Revenue per chair: $2 million - $5 million. · Gross margins: 30% average. · Repeat business: 85%.

The slide also notes that there were three locations open at the time: Miami (flagship), Ft. Lauderdale, and Daytona Beach. By listing Allergan and Galderma logos, the company aligns itself with the industry's largest pharmaceutical suppliers.

Slide 5: Corporate Overview

Slide 5 defines the company's broader mission: to build a portfolio of Beauty, Wellness, and Lifestyle businesses. The strategy is described as identifying, acquiring, and enhancing existing businesses with 'revolutionary concepts.' A photo of a seven-person team is included, though no names or specific titles are listed on this slide. The text mentions that the rollout of The LABB was facilitated through the acquisition of Reflex Productions, Inc. , providing a glimpse into the corporate structure used to facilitate the expansion.

Slide 7: $9.2 Billion Market Opportunity

This slide presents the macro-economic justification for the business. It features an area chart showing the growth of the Facial Aesthetics Market . The data points indicate the market was $2.1 billion in 2011 and is projected to reach $9.2 billion by 2020 . The chart shows a significant inflection point starting in 2018, where the growth curve steepens dramatically. This is a classic 'hockey stick' projection intended to create a sense of urgency for investors.

Slide 9: Rapid Near-Term Expansion

The expansion roadmap is visualized through a map of the United States with star icons indicating target markets. The company sets a goal of 17 additional locations by 2018 , broken down as:

California: 7 locations · Florida: 6 locations · NY/CT: 3 locations · Las Vegas: 1 location

The slide also introduces the 2019 goal of launching a franchise program and expanding into Texas and other West Coast locations. This indicates a shift from a capital-heavy corporate ownership model to a lighter, royalty-based model for long-term scaling.

Slide 13: Contact Information

The final slide repeats the cover art and provides the company's headquarters address at Trump Tower I in Sunny Isles Beach, FL . It includes a phone number, fax, and email address. The repetition of the OTC ticker reinforces the liquidity (or at least the public nature) of the investment opportunity.

What Works in This Deck

The deck is highly effective at communicating unit economics . By stating a specific revenue range per chair ($2M-$5M) and a repeat business percentage (85%), the company gives investors a clear 'money-in, money-out' framework for the retail locations. The focus on 'injectables' rather than general spa services is a smart strategic move, as these are high-frequency, high-margin medical procedures that create customer 'stickiness.'

The market timing slide (Slide 7) is also well-executed. It doesn't just show a large number; it shows a growth trend that justifies why the company is pivoting into this specific niche at this specific time. The alignment with major brands like Allergan provides a layer of third-party credibility to a relatively small public company.

What is Missing

The most glaring omission is a detailed management slide . While Slide 5 shows a group photo and mentions '25+ years of beauty industry experience,' it does not name the executives or detail their specific track records. In micro-cap public companies, the 'who' is often as important as the 'what,' and the lack of individual bios is a significant gap.

Furthermore, there is no financial 'Ask' . For a company planning to open 17 locations in two years—a capital-intensive endeavor—the deck fails to explain how much capital is being raised, at what valuation (or share price), and how that money will be allocated between construction, marketing, and corporate overhead. There is also no mention of the existing balance sheet or burn rate.

Finally, the competitive landscape is ignored. The med-spa and injectable market is highly fragmented but competitive. The deck does not explain what makes 'The LABB' superior to a local dermatologist or a competing national chain like SkinSpirit or LaserAway.

Founders: What to Copy and What to Avoid

Copy the clarity of unit economics. If you have a retail or service-based model, being able to say exactly what one 'unit' (a chair, a store, a van) produces in revenue and margin is incredibly persuasive. It allows investors to build their own mental models of your growth.

Avoid the 'anonymous team' approach. Never use a group photo as a substitute for individual credentials. Investors need to know who is responsible for the P&L. List names, previous exits, and specific industry wins.

Avoid the lack of a clear 'Ask'. An investor presentation is a sales tool. If you don't tell the audience what you need from them to achieve the roadmap you just showed, the presentation loses its momentum. Always include a slide detailing the funding requirement and the milestones that capital will unlock.

Frequently asked questions

What is the primary business model of Joey New York according to the deck?: Joey New York operates as a portfolio company that identifies and acquires existing beauty and wellness businesses. As of the 2017 deck, their primary focus was 'The LABB,' a luxury beauty suite specializing in FDA-approved injectable services like Botox and soft tissue fillers. They aim to enhance these businesses through quality management and strategic marketing talent.
What are the reported unit economics for The LABB locations?: Slide 3 reports that The LABB locations generate between $2 million and $5 million in revenue per chair. The company claims to operate with 'low overhead,' resulting in average gross margins of 30%. Additionally, the model is supported by a high customer retention rate, stated as 85% repeat business.
How does the company plan to scale its operations?: The scaling strategy is two-fold: corporate expansion and franchising. Slide 9 details a plan to open 17 additional corporate locations by 2018, targeting high-traffic markets in California, Florida, and Nevada. Following this, the company intended to launch a formal franchise program in 2019 to accelerate growth without the capital intensity of corporate-owned stores.
Who are the key partners mentioned in the presentation?: The deck highlights relationships with major manufacturers in the facial aesthetics space. Specifically, it names Allergan (the maker of Botox) and Galderma as the providers of the FDA-approved injectable fillers used at The LABB locations. This is intended to validate the medical legitimacy of their service offerings.
What information is missing from this investor deck?: The deck is missing several critical components for a comprehensive investment analysis. There is no detailed 'Team' slide listing individual names, titles, or specific past successes. It also lacks a clear 'Use of Proceeds' slide, a detailed P&L statement, and a competitive landscape analysis comparing The LABB to other med-spa chains or independent practitioners.

Cover slide of the Joey New York pitch deck — Public (OTC) 2017 — Joey New York pitch deck, slide 1 (2017)

Joey New York pitch deck: the facts

Company: Joey New York
Year: 2017
Stage: Public (OTC)
Slides: 11
Sector: Beauty / Medical Aesthetics
Deck type: Investor Presentation
Outcome: Not stated
Headquarters: Sunny Isles Beach, FL

Joey New York pitch deck PDF

The full Joey New York deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Joey New York, Inc. pitch deck was used for

This is a January 2017 investor presentation for Joey New York, a publicly traded OTC company (OTC: JOEY). The deck frames the company as shifting from traditional skincare into higher-margin medical aesthetics through The LABB, a luxury injectable beauty-bar concept built around FDA-approved services and the acquisition of Reflex Productions, Inc. It appears to have been used to support a 2017 capital raise or financing story tied to expansion of LABB locations.

Business model: Publicly traded beauty/wellness/lifestyle company that, in 2016–2017, was expanding into medical aesthetics through its LABB / BotoxLABB clinic concept and acquisition of Reflex Productions, Inc.

Round: Public (OTC)
Year: 2017
Raising: $8 million expected funding reported in 2017
Raised: $0.54 million
Investors: Kodiak Capital Group, LLC
Headquarters: Sunny Isles Beach, Florida (Trump Tower I, 16001 Collins Ave. #3202)
Industry: Beauty / Medical Aesthetics

Total funding: At least $0.54 million in funding from Kodiak Capital Group, LLC, and a reported expectation of $8 million in funding in 2017

Use of funds as presented: Expansion of The LABB / BotoxLABB aesthetic clinic concept and related growth initiatives

What happened after the Joey New York, Inc. deck

The deck’s acquisition-and-expansion story is externally corroborated at a high level, including the LABB acquisition, an OTC public-company status, and 2017 revenue growth tied to that pivot. However, the precise fundraise used with the deck, the complete terms, and whether the rollout plan was achieved are not confirmed in the retrieved sources.

August 2016: acquisition of The LABB / Reflex Productions announced in external coverage.
2017 filing reported $467,372 in revenue for the year ended February 28, 2017, up from $54,388 the prior year, with the
2017 external coverage reported the company expected to receive $8 million in funding.
2017 external coverage also reported $0.54 million in funding from Kodiak Capital Group, LLC.

What the Joey New York, Inc. deck got right

Clear transformation story. The deck has a clear strategic pivot: Joey New York is not just a skincare brand here, but a public company moving into higher-margin medical aesthetics through The LABB.
Acquisition gives the story operating substance. The company claims an acquisition-backed entry point, stating it completed the acquisition of Reflex Productions, Inc. in August 2016 and is rolling out The LABB.
Some operational footprint already exists. The presentation says three LABB locations were already open, which makes the expansion plan more credible than a purely conceptual pitch.
Specific unit economics. The deck uses concrete customer and economics claims, including 85% repeat customers and $700 average sale per patient visit, which helps make the business model legible.
External filing supports growth narrative. The parent company’s 2017 filing shows revenue growth to $467,372 from $54,388 year over year, and attributes that primarily to the acquisition and The LABB.
Geographic expansion plan. The planned expansion into multiple geographies gives the pitch a near-term growth path rather than a single-location story.

What could have been stronger

Key operating claims are not externally validated here. The deck makes revenue-per-chair and saturation claims, but the retrieved external sources do not verify the underlying unit economics or whether the projected rollout was achieved.
Raise terms are not fully disclosed. The fundraising structure is unclear from the available sources: we have evidence of 2017 funding activity, but not the specific security, valuation, or full amount closed for the deck’s raise.
Post-deck execution is hard to confirm. The deck references acquisition-led growth, but the retrieved sources do not fully verify how Reflex Productions was integrated or whether The LABB locations expanded as planned.

How an investor would read this deck

What draws attention

OTC-listed public company with a concrete pivot into a higher-margin aesthetics vertical.
Pre-existing revenue base at the parent level, with 2016–2017 filings showing revenue growth tied primarily to the Reflex Productions / The LABB acquisition.
Three LABB locations already open at the time of the deck, which supports an early operating footprint.
The deck’s economics are unusually specific, including $2 million–$5 million revenue per chair and 85% repeat customers.

Risks that stand out

The pitch is heavily dependent on acquisition and expansion execution rather than an already scaled clinic network.
The company is OTC-listed, which can imply thinner disclosure and higher financing risk than a major exchange listing.
The model relies on FDA-approved injectable services and clinic operations, which carry licensing, compliance, and reputational risk.
The deck’s economics may reflect projections rather than audited operating results, and the retrieved sources do not confirm them.

Questions this deck invites

What exactly was the financing instrument associated with this deck, and what dilution or conversion terms applied?
Were the $2 million–$5 million revenue-per-chair and 85% repeat-customer claims supported by clinic-level actuals or only modeled assumptions?
Did Joey New York actually execute the announced multi-state expansion of LABB locations within the stated 18-month window?
How much of 2017 revenue growth was recurring clinic revenue versus one-time acquisition effects?
What regulatory and medical-compliance controls were in place for injectable services across the LABB locations?

What founders can take from the Joey New York, Inc. deck

If you are pitching an acquisition-led pivot, the deck needs visible proof that the acquired asset is already contributing to revenue, not just concept momentum.
Highly specific unit economics can strengthen a story, but they also invite diligence on how the numbers were calculated and whether they were observed or modeled.
For a public-company raise, the funding narrative should make the security, amount, and use of proceeds explicit because investors will otherwise have to infer the capital structure from filings.
A clinic-rollout strategy benefits from showing existing locations first, because the presence of three open LABB sites makes the expansion plan more credible than a pure concept pitch.
In consumer health and aesthetics, a luxury brand story is not enough; investors will focus on regulatory compliance and repeat-visit behavior as the real drivers of margin.

Joey New York, Inc. pitch deck: common questions

What was Joey New York’s business in this deck?

The deck shows Joey New York as an OTC-listed public company expanding into medical aesthetics via The LABB/BotoxLABB clinic concept. Its core pitch was a transition from skincare products into injectable services and clinic roll-out.

When was this deck made and what stage was the company at?

The presentation is dated January 2017 and is labeled OTC: JOEY. The source deck is an investor presentation rather than a product brochure.

What was the company raising for?

The deck emphasizes that Joey New York had completed the acquisition of Reflex Productions, Inc. / The LABB in August 2016 and already had three LABB locations open at the time of the presentation.

How much money did Joey New York raise in connection with this deck?

External sources indicate Joey New York reported raising $0.54 million from Kodiak Capital Group, LLC in 2017, and another source reported the company expected to receive $8 million in funding in 2017. The exact financing instrument or whether the full amount closed is not confirmed in the retrieved sources.

What expansion plan did the deck promise?

The investor deck itself highlights expansion of LABB locations into Florida, Southern California, Las Vegas, Texas, and the New York City area within 18 months.

Sources

Funding and outcome facts on this page were researched on 2026-08-22 from the pages below.

Joey New York pitch deck slides

Joey New York pitch deck slide 1 of 11 — Joey New York pitch deck — slide 1 of 11

Joey New York pitch deck slide 2 of 11 — Joey New York pitch deck — slide 2 of 11

Joey New York pitch deck slide 3 of 11 — Joey New York pitch deck — slide 3 of 11

Joey New York pitch deck slide 4 of 11 — Joey New York pitch deck — slide 4 of 11

Joey New York pitch deck slide 5 of 11 — Joey New York pitch deck — slide 5 of 11

Joey New York pitch deck slide 6 of 11 — Joey New York pitch deck — slide 6 of 11

What each slide of the Joey New York pitch deck says

Slide 2

Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, future events, or future developments involving Joey New York may constitute forward-looking statements. The statements may be identified by words such as "expect," "look forward to," "anticipate," "intend," "plan," "believe," "seek," "estimate," "will," "project," or words of similar meaning. Such statements are based on the current expectations and certain assumptions of Joey New York's management, of which many are beyond control. These are subject to a number of risk…

Slide 3

Investment Highlights 0 August 2016 completed acquisition of The Labb Aesthetic Beauty Bar (LABB) = State-of-the-art luxury beauty suite offering FDA approved injectable services = $2 million - $5 million revenue per chair [F =Y = 30% average gross margins and low overhead L A = = 85% repeat business RQ Lato A Pm 0 3 LABB locations open today (Miami — flagship; Ft. Lauderdale; Daytona Beach) = Opening additional locations in Florida, Southern California, Las Vegas, Texas, and New York City area within next 18 months 0 Facial aesthetics market expected to grow to $4.6 billion by 2018 (18% CAGR) and $9.2 billion by 2020, up from $2.1 billion in 2011 = Top two services are Botox Cosmetic injec…

Slide 4

Key Stock Facts /\ (7% F \ ) Data as of January 17, 2016 1 \ a BAY al! "| — 2017 Joey New York | www.botoxlabb.com

Slide 5

Corporate Overview Joey New York focuses on building Beauty, Wellness and Lifestyle businesses. Our portfolio strategy is to identify, acquire, and enhance existing businesses or new ideas that offer revolutionary concepts. = Seek opportunities with talented teams and profitable business models = Drive growth by adding quality management with industry expertise combined with strategic sales and marketing talent Rolling out state-of-the-art, luxury beauty suite (The LABB) focused on FDA-approved injectable services through acquisition of Reflex Productions, Inc. 2017 Joey New York www.botoxlabb.com

Slide 6

The LABB First-of-its-kind aesthetic injectables beauty bar. “Borox: —~Cosmetic — mo - 2 1 Juvéderm 5 vie FAMILY OF FILLERS nm mm = Siem 8 i L Ll FE Lo MAE > } | 3 = oc [ES a Staffed by expert certified nurse practitioners g trained to design treatments using injectables to £ create the perfect look for patients. a sstylone eR Each LABB consists of 1 to 3 chairs, with $2M-$5M revenue potential per chair. 2017 Joey New York | www.botoxlabb.com »

Slide 10

Attractive Chair-Level Economics with Low Overhead S2M-S5M Revenue per chair based on saturation rates of 40% and 100% Revenue Mix Income & Expenses < 4 Services & Product Sales Product & Operating Expense ® Manufacturer Rebates = Operating Margin 2017 Joey New York www.botoxlabb.com 85% Repeat Customers $700 18 Average Sale per Average Patients per Patient Visit Chair per Day (80% Saturation) $78,400 Revenue per Chair per Week (80% Saturation; 112 Patients/Week)

Slide text above is read directly from the Joey New York deck PDF embedded on this page.